CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 172 transactions totaling $22.7M, demonstrating a bullish sentiment with $4.5M in net insider flow. The most recent transaction on Oct 30, 2025 involved a transaction of 94,405 shares valued at $198.3K.
No significant insider buying has been recorded for CSBR in the recent period.
No significant insider selling has been recorded for CSBR in the recent period.
Based on recent SEC filings, insider sentiment for CSBR is bullish with an Insider Alignment Score of 60/100 and a net flow of $4.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading CSBR stock, having executed 172 transactions in the past 90 days. The most active insider is 14 Gp, Ltd Nea (Executive), who has made 2 transactions totaling $9.9M.
Get notified when executives and directors at CSBR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | Ackerman Joel | Executive | Option Exercise | 94,405 | $2.10 | $198.3K | |
| Nov 12, 2024 | Lawrence Brainin Robert | Executive | Award | 23,030 | $4.64 | $106.9K | |
| Jan 12, 2024 | Newman Mendelson Daniel | Executive | Purchase | 1,000 | $6.50 | $6.5K | |
| Jan 11, 2024 | Newman Mendelson Daniel | Executive | Purchase | 2,000 | $6.27 | $12.5K | |
| Jan 10, 2024 | Newman Mendelson Daniel | Executive | Purchase | 2,944 | $6.31 | $18.6K | |
| Jan 9, 2024 | Newman Mendelson Daniel | Executive | Purchase | 3,000 | $6.25 | $18.8K | |
| Jan 8, 2024 | Newman Mendelson Daniel | Executive | Purchase | 1,000 | $6.15 | $6.2K | |
| Jan 5, 2024 | Newman Mendelson Daniel | Executive | Purchase | 2,000 | $6.09 | $12.2K | |
| Jan 4, 2024 | Newman Mendelson Daniel | Executive | Purchase | 3,000 | $6.12 | $18.4K | |
| Jan 3, 2024 | Newman Mendelson Daniel | Executive | Purchase | 500 | $5.83 | $2.9K | |
| Dec 21, 2023 | Newman Mendelson Daniel | Executive | Purchase | 2,500 | $4.92 | $12.3K | |
| Dec 20, 2023 | Newman Mendelson Daniel | Executive | Purchase | 2,100 | $4.82 | $10.1K | |
| Dec 19, 2023 | Newman Mendelson Daniel | Executive | Purchase | 5,000 | $4.75 | $23.8K | |
| Nov 3, 2023 | Lawrence Brainin Robert | Executive | Award | 19,070 | $5.51 | $105.1K | |
| Oct 17, 2023 | Ackerman Joel | Executive | Option Exercise | 114,552 | $2.10 | $240.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 92 | $13.6M | 35.2% |
Sale(S) | 13 | $9.1M | 23.5% |
Exercise (Options)(X) | 4 | $7.5M | 19.4% |
Exercise(M) | 29 | $3.8M | 9.7% |
Gift(G) | 6 | $3.7M | 9.7% |
Payment(F) | 8 | $507.0K | 1.3% |
Award(A) | 10 | $410.8K | 1.1% |
Other(J) | 9 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Insider activity at CHAMPIONS BIOTECHNOLOGY, INC. shows mixed signals across all time. While $13.6M in purchases indicates some executive confidence,$9.1M in sales balances the picture, resulting in a modest net flow of $4.5M.16 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, 14 Gp, Ltd Nea, has transacted $9.9M during this period.